St Peter’s Trust is unique in the UK in funding research on disorders that affect any part of the urinary tract from the kidney to the bladder to the urethra.
The Trust was established in 1970 to fund the research of the St Peters group of hospitals and the postgraduate Institute of Urology. When the clinical and research base was moved to University College London and the Royal Free Hospital in 2006, the Trust moved with them.
We are very pleased to announce that applications are now invited from staff (in honorary or substantive posts) of the former Institute of Urology, the Centre for Nephrology (Royal Free and University College School of Medicine) and the ‘St Peter’s Hospital’ group of urologists at UCLH and the Royal Free Hospital.
- Kidney disease – 5th largest cause of death
- Prostate cancer – 30,000 diagnoses a year
- Enlarged prostate – affects 50% of men by 50 years old
- Cystitis – affects 3% of women every year
- Diabetes – leads to kidney disease
- Bladder malfunction – misery for many
Research in to practice
Research is the basis for progress and leads to new surgical, medical and genetic treatments. In the (nearly) half century of the Trust’s life, almost all of the treatments for urological and kidney diseases have radically changed or, at least, improved. For example, new imaging for kidney cancer, funded by St Peters, is already reducing the burden of investigation for patients.
Read more about current research projects.
Kidney stones affect 12% of men and 5% of women by the age of 70.
This x-ray shows a stone in the kidney, showing as a white object to the right of the spine. This stone is about 15mm in diameter and therefore too large to pass by itself and is usually painful. To enable patients to get rid of the stone modern treatments disintegrate it without an operation.
Outcome of disintegration treatment
Modern treatment fragments the stone without surgery which will then pass naturally as dust.